Moritz Bewarder

934 total citations
44 papers, 339 citations indexed

About

Moritz Bewarder is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Moritz Bewarder has authored 44 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 9 papers in Genetics. Recurrent topics in Moritz Bewarder's work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Moritz Bewarder is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). Moritz Bewarder collaborates with scholars based in Germany, United States and France. Moritz Bewarder's co-authors include Lorenz Thurner, Dominic Kaddu‐Mulindwa, Stephan Stilgenbauer, Konstantinos Christofyllakis, Robert Bals, Manfred Ahlgrimm, Joerg Thomas Bittenbring, Igor Age Kos, Philipp M. Lepper and Diana Aicher and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Moritz Bewarder

40 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Moritz Bewarder Germany	10	114	102	63	52	45	44	339
Francesco Grimaldi Italy	11	121 1.1×	111 1.1×	71 1.1×	74 1.4×	55 1.2×	29	470
Jonas Ahlbrecht Germany	7	73 0.6×	116 1.1×	42 0.7×	31 0.6×	62 1.4×	7	405
A. Klepfish Israel	15	147 1.3×	85 0.8×	64 1.0×	102 2.0×	44 1.0×	27	484
Oscar C Estalilla United States	7	109 1.0×	116 1.1×	58 0.9×	54 1.0×	38 0.8×	12	326
Aparna Harbhajanka United States	11	131 1.1×	89 0.9×	133 2.1×	19 0.4×	67 1.5×	56	525
G. А. Novichkova Russia	11	87 0.8×	44 0.4×	58 0.9×	89 1.7×	79 1.8×	147	457
Jirka Grosse Germany	10	58 0.5×	58 0.6×	68 1.1×	53 1.0×	45 1.0×	33	368
Mahmut Bayık Türkiye	12	113 1.0×	123 1.2×	43 0.7×	93 1.8×	33 0.7×	35	443
Etienne Mahé Canada	10	86 0.8×	80 0.8×	31 0.5×	47 0.9×	61 1.4×	36	345
Gesina Hansel Germany	12	149 1.3×	100 1.0×	59 0.9×	22 0.4×	46 1.0×	49	543

Countries citing papers authored by Moritz Bewarder

Since Specialization

Citations

This map shows the geographic impact of Moritz Bewarder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moritz Bewarder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moritz Bewarder more than expected).

Fields of papers citing papers by Moritz Bewarder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moritz Bewarder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moritz Bewarder. The network helps show where Moritz Bewarder may publish in the future.

Co-authorship network of co-authors of Moritz Bewarder

This figure shows the co-authorship network connecting the top 25 collaborators of Moritz Bewarder. A scholar is included among the top collaborators of Moritz Bewarder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moritz Bewarder. Moritz Bewarder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berger, Fabian K., Walter Schulz‐Schaeffer, Klaus Faßbender, et al.. (2025). Severe coxsackie virus B5 encephalitis mimics autoimmune limbic encephalitis in a young woman under long-term B-cell depletion with ocrelizumab: A case report. Multiple Sclerosis Journal. 31(10). 1258–1261.

Nigdelis, Meletios P., Moritz Bewarder, Joerg Thomas Bittenbring, et al.. (2025). Secondary hemophagocytic lymphohistiocytosis associated with adjuvant pembrolizumab therapy in a young patient with triple-negative breast cancer: a case report with literature review. Archives of Gynecology and Obstetrics. 312(5). 1813–1820. 1 indexed citations

Neumann, Frank, Konstantinos Christofyllakis, Igor Age Kos, et al.. (2024). Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas. Scientific Reports. 14(1). 9571–9571. 1 indexed citations

Fadle, Natalie, Evi Regitz, Igor Age Kos, et al.. (2024). Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis. Immunology Letters. 270. 106926–106926. 2 indexed citations

Denker, Sophy, Dominic Kaddu‐Mulindwa, Viola Poeschel, et al.. (2024). Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study. European Journal Of Haematology. 113(5). 675–684. 1 indexed citations

Bewarder, Moritz, Dominic Kaddu‐Mulindwa, Igor Age Kos, et al.. (2023). Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP. Haematologica. 108(10). 2844–2849. 2 indexed citations

Christofyllakis, Konstantinos, Frank Neumann, Moritz Bewarder, et al.. (2023). Vitamin D Enhances Immune Effector Pathways of NK Cells Thus Providing a Mechanistic Explanation for the Increased Effectiveness of Therapeutic Monoclonal Antibodies. Nutrients. 15(16). 3498–3498. 5 indexed citations

Kos, Igor Age, Joerg Thomas Bittenbring, Manfred Ahlgrimm, et al.. (2022). Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2. Expert Review of Vaccines. 21(11). 1683–1689. 1 indexed citations

Kaddu‐Mulindwa, Dominic, Philipp Gödel, Nadine Kutsch, et al.. (2022). Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(7). e498–e506. 1 indexed citations

10.

Kaddu‐Mulindwa, Dominic, Lorenz Thurner, Konstantinos Christofyllakis, Moritz Bewarder, & Igor Age Kos. (2022). Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives. Cancers. 14(12). 3019–3019. 7 indexed citations

11.

Bewarder, Moritz, Stephan Stilgenbauer, Lorenz Thurner, & Dominic Kaddu‐Mulindwa. (2021). Current Treatment Options in CLL. Cancers. 13(10). 2468–2468. 30 indexed citations

12.

Kaddu‐Mulindwa, Dominic, Bettina Altmann, Gerhard Held, et al.. (2021). FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials. European Journal of Nuclear Medicine and Molecular Imaging. 48(11). 3550–3559. 20 indexed citations

13.

Thurner, Lorenz, Natalie Fadle, Joerg Thomas Bittenbring, et al.. (2021). LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome. Blood. 137(23). 3251–3258. 7 indexed citations

14.

Kaddu‐Mulindwa, Dominic, Christian Berdel, Stephan Stilgenbauer, et al.. (2021). Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial. Leukemia & lymphoma. 63(2). 326–334. 2 indexed citations

15.

Kaddu‐Mulindwa, Dominic, Jürgen Rissland, Sigrun Smola, et al.. (2021). IgG seroprevalence of COVID‐19 among people living with HIV or at high risk of HIV in south‐west Germany: A seroprevalence study. HIV Medicine. 23(5). 564–569. 3 indexed citations

16.

Kaddu‐Mulindwa, Dominic, Maciej Rosołowski, Marita Ziepert, et al.. (2020). VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B‐cell lymphoma. European Journal Of Haematology. 106(1). 100–104. 4 indexed citations

17.

Bewarder, Moritz, Stephan Stilgenbauer, Konstantinos Christofyllakis, et al.. (2020). Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma. Frontiers in Oncology. 10. 580364–580364. 5 indexed citations

18.

Thurner, Lorenz, Sylvia Hartmann, Frank Neumann, et al.. (2020). Role of Specific B-Cell Receptor Antigens in Lymphomagenesis. Frontiers in Oncology. 10. 604685–604685. 13 indexed citations

19.

Bewarder, Moritz, Gerhard Held, Lorenz Thurner, et al.. (2020). Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential. Cancer Immunology Immunotherapy. 69(8). 1535–1548. 4 indexed citations

20.

Aicher, Diana, et al.. (2013). Aortic Valve Function After Bicuspidization of the Unicuspid Aortic Valve. The Annals of Thoracic Surgery. 95(5). 1545–1550. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact